Client News

Cytokinetics Announces Phase IIa Clinical Trial Results Relating to CK-1827452 in Patients with Ischemic Cardiomyopathy and Angina
12/18/2008

Cytokinetics, Inc.

Cylene Pharmaceuticals Initiates Phase II Clinical Trial of Quarfloxin (CX-3543) in Patients with Carcinoid/Neuroendocrine Tumors
12/15/2008

Cylene Pharmaceuticals

Cytokinetics Announces Clinical and Preclinical Data Regarding Ispinesib Presented at the 31st Annual San Antonio Breast Cancer Symposium
12/12/2008

Cytokinetics, Inc.

Gilead Sciences Files Patent Infringement Lawsuit Against Teva Pharmaceuticals
12/12/2008

Gilead Sciences, Inc.